IL160798A0 - Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations - Google Patents
Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsInfo
- Publication number
- IL160798A0 IL160798A0 IL16079804A IL16079804A IL160798A0 IL 160798 A0 IL160798 A0 IL 160798A0 IL 16079804 A IL16079804 A IL 16079804A IL 16079804 A IL16079804 A IL 16079804A IL 160798 A0 IL160798 A0 IL 160798A0
- Authority
- IL
- Israel
- Prior art keywords
- rifaximin
- processes
- production
- medicinal preparations
- polymorphous forms
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/02—Induction heating
- H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
- H05B6/12—Cooking devices
- H05B6/1209—Cooking devices induction cooking plates or the like and devices to be used in combination with them
- H05B6/1236—Cooking devices induction cooking plates or the like and devices to be used in combination with them adapted to induce current in a coil to supply power to a device and electrical heating devices powered in this way
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/02—Induction heating
- H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
- H05B6/12—Cooking devices
- H05B6/1209—Cooking devices induction cooking plates or the like and devices to be used in combination with them
- H05B6/1245—Cooking devices induction cooking plates or the like and devices to be used in combination with them with special coil arrangements
- H05B6/1263—Cooking devices induction cooking plates or the like and devices to be used in combination with them with special coil arrangements using coil cooling arrangements
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Electromagnetism (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002144A ITMI20032144A1 (it) | 2003-11-07 | 2003-11-07 | Forme polimorfe di rifaximina, processi per ottenerle e |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160798A0 true IL160798A0 (en) | 2004-08-31 |
Family
ID=33187382
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16079804A IL160798A0 (en) | 2003-11-07 | 2004-03-09 | Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
IL174271A IL174271A (en) | 2003-11-07 | 2006-03-12 | Purified alpha, beta, gamma polymorphs of rifaximin antibiotics and process for their production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL174271A IL174271A (en) | 2003-11-07 | 2006-03-12 | Purified alpha, beta, gamma polymorphs of rifaximin antibiotics and process for their production |
Country Status (38)
Country | Link |
---|---|
US (5) | US7045620B2 (es) |
EP (6) | EP1557421B1 (es) |
JP (5) | JP2005139161A (es) |
KR (4) | KR20050043589A (es) |
CN (4) | CN1613858A (es) |
AR (3) | AR043547A1 (es) |
AT (3) | ATE421965T1 (es) |
AU (2) | AU2004200964A1 (es) |
BR (2) | BRPI0402382A (es) |
CA (2) | CA2460384A1 (es) |
CL (1) | CL2004000498A1 (es) |
CO (1) | CO5560083A1 (es) |
CY (3) | CY1108017T1 (es) |
DE (4) | DE602004019298D1 (es) |
DK (3) | DK1557421T3 (es) |
ES (3) | ES2320161T3 (es) |
HK (3) | HK1092151A1 (es) |
HR (2) | HRP20040265A2 (es) |
IL (2) | IL160798A0 (es) |
IT (1) | ITMI20032144A1 (es) |
JO (1) | JO2470B1 (es) |
MA (1) | MA27069A1 (es) |
MD (1) | MD3653G8 (es) |
ME (1) | ME00424B (es) |
MX (2) | MXPA04002353A (es) |
NO (1) | NO334950B1 (es) |
NZ (1) | NZ531622A (es) |
PL (3) | PL1676847T3 (es) |
PT (3) | PT1557421E (es) |
RS (4) | RS54569B1 (es) |
RU (1) | RU2270200C2 (es) |
SI (3) | SI1676847T1 (es) |
TN (2) | TNSN04044A1 (es) |
TW (1) | TWI285107B (es) |
UA (1) | UA86384C2 (es) |
WO (1) | WO2005044823A2 (es) |
YU (1) | YU24804A (es) |
ZA (1) | ZA200401948B (es) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US7923553B2 (en) * | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
US20080262024A1 (en) * | 2003-11-07 | 2008-10-23 | Giuseppe Claudio Viscomi | Rifaximin compositions and method of use |
US7902206B2 (en) * | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
ITMI20032144A1 (it) * | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
US7906542B2 (en) * | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
SI1698630T1 (sl) * | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
DK2054066T3 (en) | 2006-08-02 | 2015-06-08 | Salix Pharmaceuticals Inc | METHODS OF TREATMENT OF RADIATE ENTERITIS |
ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
EP2069363B1 (en) * | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
ITMI20071241A1 (it) * | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
EP2011486B2 (en) * | 2007-07-06 | 2015-08-12 | Lupin Ltd. | Pharmaceutical compositions of rifaximin |
US8383151B2 (en) * | 2007-07-06 | 2013-02-26 | Lupin Limited | Pharmaceutical compositions of rifaximin |
AU2016203925B2 (en) * | 2007-07-06 | 2016-10-20 | Lupin Limited | Pharmaceutical compositions of rifaximin |
US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
US8486956B2 (en) * | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
ME01032B (me) * | 2008-02-25 | 2012-10-20 | Salix Pharmaceuticals Ltd | FORME RIFAKSIMINA l NJIHOVA UPOTREBA |
US11779571B2 (en) | 2008-02-26 | 2023-10-10 | Salix Pharmaceuticals, Inc. | Methods for treating irritable bowel syndrome (IBS) |
US8309569B2 (en) | 2008-02-26 | 2012-11-13 | Salix Pharmaceuticals, Ltd. | Methods for treating diarrhea-associated irritable bowel syndrome |
US20090324736A1 (en) | 2008-05-07 | 2009-12-31 | Salix Pharmaceuticals, Ltd. | Methods of treating bowel diseases by administering a bowel cleanser and an antibiotic |
CA2736285C (en) | 2008-09-26 | 2016-08-23 | Aska Pharmaceutical Co., Ltd. | Agent for preventing and/or treating functional gastrointestinal disorder |
US20100317681A1 (en) * | 2009-06-15 | 2010-12-16 | Salix Pharmaceuticals, Ltd. | Modulation of systemic exposure to rifaximin |
US7928115B2 (en) * | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
HUE065491T2 (hu) | 2008-10-02 | 2024-05-28 | Salix Pharmaceuticals Ltd | A hepatikus enkefalopátia kezelése rifaximin alkalmazásával |
KR20110107806A (ko) | 2008-12-10 | 2011-10-04 | 시플라 리미티드 | 리팍시민 복합체 |
IT1397617B1 (it) * | 2009-04-20 | 2013-01-18 | Alfa Wassermann Spa | Nuovi derivati della rifamicina |
MX2011012829A (es) * | 2009-06-02 | 2012-02-28 | Salix Pharmaceuticals Ltd | Metodos para tratar encefalopatia hepatica. |
MX2012002895A (es) | 2009-09-13 | 2012-05-22 | Salix Pharmaceuticals Ltd | Metodos para tratar el sindrome de intestino irritado (ibs). |
KR102456997B1 (ko) * | 2009-10-27 | 2022-10-19 | 루핀 리미티드 | 리팍시민의 고형 분산물 |
WO2011061748A1 (en) * | 2009-11-19 | 2011-05-26 | Strides Arcolab Limited | Rifaximin premix |
NZ600362A (en) | 2009-11-23 | 2014-08-29 | Cipla Ltd | Topical foam composition |
WO2011080691A1 (en) | 2009-12-28 | 2011-07-07 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
EP3650022A1 (en) | 2010-02-18 | 2020-05-13 | Salix Pharmaceuticals, Ltd. | Methods for treating rifampin resistant clostridium difficilis infections |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
CN103269587A (zh) * | 2010-06-03 | 2013-08-28 | 萨利克斯药品有限公司 | 利福昔明的新形式及其用途 |
US8883795B2 (en) * | 2010-06-16 | 2014-11-11 | Apotex Pharmachem Inc. | Polymorphic forms of Rifaximin |
CA2804635C (en) | 2010-07-12 | 2019-09-10 | Salix Pharmaceuticals, Ltd. | Formulations of rifaximin and uses thereof |
WO2012035544A2 (en) | 2010-09-13 | 2012-03-22 | Sequent Scientific Ltd. | A novel polymorphic form of rifaximin and process for its preparation |
IT1403847B1 (it) | 2010-09-22 | 2013-11-08 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina e loro uso. |
WO2012060675A1 (es) * | 2010-11-05 | 2012-05-10 | Interquim, S.A. De C.V. | Proceso para la preparación de rifaximina amorfa |
WO2012076832A1 (en) * | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
AU2012214239B2 (en) | 2011-02-11 | 2016-06-30 | Salix Pharmaceuticals, Ltd. | Forms of Rifaximin and uses thereof |
CA2834829A1 (en) | 2011-05-02 | 2012-11-08 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
WO2012155981A1 (en) | 2011-05-19 | 2012-11-22 | Friulchem Spa | New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby |
ITMI20110890A1 (it) * | 2011-05-19 | 2012-11-20 | A M S A Anonima Materie Sint & Affini S P A | Polimorfo di rifaximina e processo per la sua preparazione |
ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
WO2013067394A1 (en) | 2011-11-02 | 2013-05-10 | Salix Pharmaceuticals, Ltd | Methods for treating irritable bowel syndrome (ibs) and infections |
JP2013184902A (ja) * | 2012-03-06 | 2013-09-19 | Aska Pharmaceutical Co Ltd | リファキシミン含有結晶 |
CA2876737A1 (en) * | 2012-06-13 | 2013-12-19 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
WO2014091432A1 (en) | 2012-12-12 | 2014-06-19 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of rifaximin |
US20160038468A1 (en) | 2013-03-15 | 2016-02-11 | Alfa Wassermann S.P.A. | Rifaximin for use in the treating of vaginal infections |
JP2016516988A (ja) | 2013-03-15 | 2016-06-09 | アルファ ワッセルマン ソシエタ ペル アチオニAlfa Wassermann S.P.A. | 膣感染症を診断するための方法 |
AU2014252219B2 (en) | 2013-04-12 | 2018-11-22 | Alfasigma S.P.A. | NSAID administration and related compositions, methods and systems. |
US9018225B1 (en) | 2013-07-26 | 2015-04-28 | Novel Laboratories | Rifaximin crystalline forms and methods of preparation thereof |
EP2927235B1 (en) | 2014-03-31 | 2017-02-08 | Euticals S.P.A. | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
US9765088B2 (en) | 2014-04-19 | 2017-09-19 | Granules India Limited | Process for the preparation of rifamycin derivatives |
WO2015171493A1 (en) | 2014-05-04 | 2015-11-12 | Salix Pharmaceuticals, Inc. | Ibs microbiota and uses thereof |
RS59250B1 (sr) | 2014-05-12 | 2019-10-31 | Alfasigma Spa | Novi solvatni kristalni oblik rifaksimina, njegova proizvodnja, kompozicije i upotreba |
CN106999477B (zh) * | 2014-06-30 | 2020-04-10 | 萨利克斯药品公司 | 用于重复治疗肠易激综合征(ibs)的方法 |
CN104083324B (zh) * | 2014-07-10 | 2017-05-10 | 青岛动保国家工程技术研究中心有限公司 | 一种利福昔明的兽用悬乳剂及其制备方法和应用 |
EP2982764A1 (en) | 2014-08-05 | 2016-02-10 | ALFA WASSERMANN S.p.A. | Identification of vaginal bacteria |
CN104274391B (zh) * | 2014-10-08 | 2017-02-01 | 哈尔滨坤盟医药科技有限公司 | 一种含利福昔明的药物制剂 |
WO2017021975A1 (en) * | 2015-08-06 | 2017-02-09 | Msn Laboratories Private Limited | Process for the preparation of crystalline forms of rifaximin |
ES2700423T3 (es) | 2016-03-24 | 2019-02-15 | Sandoz Ag | Composición farmacéutica que contiene rifaximina alfa y delta |
EP3536311B1 (en) | 2016-03-24 | 2021-12-22 | Sandoz AG | Storage stable composition comprising rifaximin alpha |
US9988398B2 (en) * | 2016-06-07 | 2018-06-05 | Cadila Healthcare Limited | Crystalline form of rifaximin and process for its preparation |
WO2018064472A1 (en) | 2016-09-30 | 2018-04-05 | Salix Pharmaceuticals, Ltd. | Solid dispersion forms of rifaximin |
CN106632396B (zh) * | 2017-01-06 | 2019-01-11 | 成都樵枫科技发展有限公司 | γ晶型利福昔明的制备方法和用途 |
AU2018211305B2 (en) | 2017-04-26 | 2019-07-25 | Sandoz Ag | Oral dosage form comprising rifaximin in form beta |
EP3645539B1 (en) | 2017-06-26 | 2021-04-07 | Biofer S.p.A. | Pyrido-imidazo rifamycin derivatives as antibacterial agent |
WO2020245214A1 (en) | 2019-06-03 | 2020-12-10 | Bausch Health Ireland Limited | Use of methylnaltrexone and rifaximin for treatment of increased gut permeability or associated disorders |
AU2020355603A1 (en) | 2019-09-24 | 2022-03-17 | Bausch Health Ireland Limited | Rifaximin liquid formulations |
WO2021191312A1 (en) | 2020-03-24 | 2021-09-30 | Bausch Health Ireland Limited | Methods of treating covid-19 with rifaximin |
WO2021229480A1 (en) * | 2020-05-15 | 2021-11-18 | Atra Pharmaceuticals Limited | Polymorph of rifaximin, process for the preparation thereof and pharmaceutical composition containing rifaximin |
EP4171520A1 (en) | 2020-06-26 | 2023-05-03 | Bausch Health Ireland Limited | Targeted release rifaximin compositions |
US20230398102A1 (en) | 2020-10-29 | 2023-12-14 | Bausch Health Ireland Limited | Rifaximin liquid formulations for use inthe treatment of sickle cell disease |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241785A (en) * | 1978-07-24 | 1980-12-30 | Peerless Of America, Inc. | Heat exchangers and method of making same |
IT1154655B (it) * | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
IT1199374B (it) * | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
CA1215976A (en) | 1984-05-15 | 1986-12-30 | Vincenzo Cannata | New process for the synthesis of imidazo rifamycins |
IT1199413B (it) | 1984-09-26 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
GB8816620D0 (en) * | 1988-07-13 | 1988-08-17 | Lepetit Spa | Rifapentine hydrohalides |
EP0536197B1 (en) * | 1990-06-29 | 1995-07-26 | GRUPPO LEPETIT S.p.A. | Pure crystalline form of rifapentine |
WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
UA75365C2 (en) * | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
EP1330427A1 (en) * | 2000-10-31 | 2003-07-30 | Ciba SC Holding AG | Crystalline forms of venlafaxine hydrochloride |
IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
ITMI20032144A1 (it) * | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
US20050262269A1 (en) | 2004-05-20 | 2005-11-24 | Pike Jimmy D | System and method for information handling system PCI express advanced switching |
SI1698630T1 (sl) | 2005-03-03 | 2015-01-30 | Alfa Wassermann S.P.A. | Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih |
EP2069363B1 (en) * | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
WO2008115572A1 (en) | 2007-03-21 | 2008-09-25 | Theraquest Biosciences, Inc. | Methods and compositions of nsaids |
ITMI20071241A1 (it) | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
US8383151B2 (en) * | 2007-07-06 | 2013-02-26 | Lupin Limited | Pharmaceutical compositions of rifaximin |
EP2011486B2 (en) | 2007-07-06 | 2015-08-12 | Lupin Ltd. | Pharmaceutical compositions of rifaximin |
US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
WO2009047801A1 (en) | 2007-10-10 | 2009-04-16 | Lupin Limited | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
ME01032B (me) | 2008-02-25 | 2012-10-20 | Salix Pharmaceuticals Ltd | FORME RIFAKSIMINA l NJIHOVA UPOTREBA |
-
2003
- 2003-11-07 IT IT002144A patent/ITMI20032144A1/it unknown
- 2003-12-05 US US10/728,090 patent/US7045620B2/en not_active Expired - Lifetime
-
2004
- 2004-03-09 DK DK04005541T patent/DK1557421T3/da active
- 2004-03-09 AT AT06004219T patent/ATE421965T1/de active
- 2004-03-09 ES ES06004220T patent/ES2320161T3/es not_active Expired - Lifetime
- 2004-03-09 PL PL06004219T patent/PL1676847T3/pl unknown
- 2004-03-09 PL PL04005541T patent/PL1557421T3/pl unknown
- 2004-03-09 DE DE602004019298T patent/DE602004019298D1/de not_active Expired - Lifetime
- 2004-03-09 ES ES06004219T patent/ES2320160T4/es not_active Expired - Lifetime
- 2004-03-09 EP EP04005541A patent/EP1557421B1/en not_active Expired - Lifetime
- 2004-03-09 DE DE602004019296T patent/DE602004019296D1/de not_active Expired - Lifetime
- 2004-03-09 DE DE04005541T patent/DE04005541T1/de active Pending
- 2004-03-09 ES ES04005541T patent/ES2244364T3/es not_active Expired - Lifetime
- 2004-03-09 PT PT04005541T patent/PT1557421E/pt unknown
- 2004-03-09 AT AT06004220T patent/ATE421966T1/de active
- 2004-03-09 NZ NZ531622A patent/NZ531622A/en not_active IP Right Cessation
- 2004-03-09 PT PT06004220T patent/PT1676848E/pt unknown
- 2004-03-09 PL PL06004220T patent/PL1676848T3/pl unknown
- 2004-03-09 SI SI200431074T patent/SI1676847T1/sl unknown
- 2004-03-09 CA CA002460384A patent/CA2460384A1/en not_active Abandoned
- 2004-03-09 SI SI200430297T patent/SI1557421T1/sl unknown
- 2004-03-09 EP EP06004219A patent/EP1676847B1/en not_active Expired - Lifetime
- 2004-03-09 PT PT06004219T patent/PT1676847E/pt unknown
- 2004-03-09 SI SI200431070T patent/SI1676848T1/sl unknown
- 2004-03-09 IL IL16079804A patent/IL160798A0/xx unknown
- 2004-03-09 EP EP06004220A patent/EP1676848B1/en not_active Expired - Lifetime
- 2004-03-09 DE DE602004006367.3T patent/DE602004006367C5/de not_active Expired - Lifetime
- 2004-03-09 AT AT04005541T patent/ATE361927T1/de active
- 2004-03-09 DK DK06004220T patent/DK1676848T3/da active
- 2004-03-09 DK DK06004219T patent/DK1676847T3/da active
- 2004-03-10 ZA ZA200401948A patent/ZA200401948B/xx unknown
- 2004-03-10 AU AU2004200964A patent/AU2004200964A1/en not_active Abandoned
- 2004-03-11 MX MXPA04002353A patent/MXPA04002353A/es unknown
- 2004-03-11 AR ARP040100781A patent/AR043547A1/es not_active Application Discontinuation
- 2004-03-11 CO CO04022467A patent/CO5560083A1/es not_active Application Discontinuation
- 2004-03-11 CL CL200400498A patent/CL2004000498A1/es unknown
- 2004-03-16 CN CNA2004100477623A patent/CN1613858A/zh active Pending
- 2004-03-16 TW TW093106943A patent/TWI285107B/zh not_active IP Right Cessation
- 2004-03-17 KR KR1020040017892A patent/KR20050043589A/ko not_active Application Discontinuation
- 2004-03-17 JP JP2004076458A patent/JP2005139161A/ja active Pending
- 2004-03-18 HR HRP20040265 patent/HRP20040265A2/hr not_active Application Discontinuation
- 2004-03-18 RU RU2004108953/04A patent/RU2270200C2/ru active
- 2004-03-18 JO JO200433A patent/JO2470B1/en active
- 2004-03-19 BR BR0402382-0A patent/BRPI0402382A/pt not_active IP Right Cessation
- 2004-03-19 TN TNP2004000044A patent/TNSN04044A1/en unknown
- 2004-03-19 YU YU24804A patent/YU24804A/sh unknown
- 2004-03-24 MA MA27590A patent/MA27069A1/fr unknown
- 2004-04-11 UA UAA200602354A patent/UA86384C2/uk unknown
- 2004-11-04 CA CA2538546A patent/CA2538546C/en active Active
- 2004-11-04 ME MEP-2008-633A patent/ME00424B/me unknown
- 2004-11-04 AU AU2004287601A patent/AU2004287601B8/en active Active
- 2004-11-04 EP EP10004590A patent/EP2208730A1/en not_active Withdrawn
- 2004-11-04 RS RS20150291A patent/RS54569B1/en unknown
- 2004-11-04 RS YUP-2006/0168A patent/RS20060168A/sr unknown
- 2004-11-04 WO PCT/EP2004/012490 patent/WO2005044823A2/en active Application Filing
- 2004-11-04 KR KR1020057013910A patent/KR100855084B1/ko active IP Right Review Request
- 2004-11-04 EP EP10004589A patent/EP2210893A1/en not_active Withdrawn
- 2004-11-04 CN CN2008100869308A patent/CN101260114B/zh active Active
- 2004-11-04 RS RS20060168A patent/RS54568B1/en unknown
- 2004-11-04 CN CN2004800030228A patent/CN1886408B/zh active Active
- 2004-11-04 KR KR1020077026410A patent/KR100867751B1/ko active IP Right Grant
- 2004-11-04 KR KR1020077026409A patent/KR100883216B1/ko active IP Right Grant
- 2004-11-04 EP EP04797615A patent/EP1682556A2/en not_active Withdrawn
- 2004-11-04 MD MDA20060080A patent/MD3653G8/ro active IP Right Grant
- 2004-11-04 MX MXPA06002644A patent/MXPA06002644A/es active IP Right Grant
- 2004-11-04 CN CN2008100869327A patent/CN101260115B/zh active Active
- 2004-11-04 JP JP2006537252A patent/JP5199576B2/ja active Active
- 2004-11-04 BR BRPI0407149A patent/BRPI0407149A8/pt not_active Application Discontinuation
- 2004-11-04 RS RS20150292A patent/RS54571B1/en unknown
-
2005
- 2005-05-24 US US11/135,651 patent/US20050272754A1/en not_active Abandoned
- 2005-08-04 HK HK06113864.0A patent/HK1092151A1/xx not_active IP Right Cessation
- 2005-08-04 HK HK05106702A patent/HK1073657A1/xx not_active IP Right Cessation
- 2005-08-04 HK HK06113863.1A patent/HK1092150A1/xx not_active IP Right Cessation
-
2006
- 2006-03-01 TN TNP2006000069A patent/TNSN06069A1/en unknown
- 2006-03-08 HR HRP20060093AA patent/HRP20060093B1/hr active IP Right Grant
- 2006-03-08 NO NO20061110A patent/NO334950B1/no unknown
- 2006-03-12 IL IL174271A patent/IL174271A/en active IP Right Grant
-
2007
- 2007-07-02 CY CY20071100875T patent/CY1108017T1/el unknown
- 2007-10-17 US US11/873,841 patent/US7915275B2/en active Active
-
2009
- 2009-03-23 CY CY20091100319T patent/CY1108909T1/el unknown
- 2009-04-09 CY CY20091100414T patent/CY1108964T1/el unknown
-
2010
- 2010-11-19 JP JP2010259453A patent/JP5635376B2/ja active Active
- 2010-11-19 JP JP2010259452A patent/JP2011057698A/ja not_active Withdrawn
-
2011
- 2011-03-04 US US13/041,348 patent/US8404704B2/en active Active
- 2011-03-04 US US13/041,346 patent/US8173801B2/en active Active
- 2011-06-23 AR ARP110102194A patent/AR081992A2/es not_active Application Discontinuation
- 2011-06-23 AR ARP110102193A patent/AR081991A2/es not_active Application Discontinuation
-
2014
- 2014-07-04 JP JP2014138697A patent/JP2014177500A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160798A0 (en) | Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations | |
ZA200707397B (en) | New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations | |
IL173204A0 (en) | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments | |
PL372931A1 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
PL378065A1 (pl) | Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych | |
IL191790B (en) | The history of xanthine, their production and their use as medicines | |
HK1089768A1 (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
IL171170A (en) | History of itensinoids and their pharmaceutical preparations, methods of preparation and use thereof | |
ZA200604432B (en) | Thiozolidinones production and use thereof as medicaments | |
IL169818A0 (en) | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them | |
HK1082744A1 (en) | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | |
HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
EP1731139A4 (en) | PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR | |
EP1820798A4 (en) | 7-CYCLE CYCLIC COMPOUND, PROCESS FOR PRODUCTION AND MEDICINAL USE THEREOF | |
GB2426704B (en) | Herbal oro-dental care composition and process for preparing the same | |
PL377741A1 (pl) | Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego | |
AU2003255612A8 (en) | Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments | |
HK1100424A1 (en) | Oral preparations and process for production thereof | |
PL1502590T3 (pl) | Pochodne oksymów heterocyklicznych, ich sposób wytwarzania i ich zastosowanie w leczeniu cukrzycy typu II | |
TWI340745B (en) | Novel diketopiperazine derivatives and the processes for preparation thereof | |
TWI318211B (en) | Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments | |
IL174975A0 (en) | 2-phenyl-benzofuran derivatives, method for the production thereof and their use | |
EP1482937A4 (en) | NOVEL TYLOINDICINS AND COMPOUNDS THEREFOR, PHARMACEUTICAL COMPOSITIONS AND METHODS | |
EP1648918A4 (en) | NONGLYCOSYLATED HUMAN ALPHA-FETOPROTEIN, METHOD OF MANUFACTURE AND APPLICATIONS THEREOF | |
IL164248A0 (en) | Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use |